Anthem Biosciences Stock Screener | Share Price & Fundamental Analysis
ANTHEM
Biotechnology
Screen Anthem Biosciences share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹655.50
▲
12.70 (1.98%)
Share Price BSE
₹655.65
▲
13.45 (2.09%)
Market Cap
₹36,813.54 Cr.
P/E Ratio (TTM)
69.88
P/B Ratio
13.10
EPS (TTM)
₹8.07
Dividend Yield
-
Debt to Equity
0.08
52W High
₹866.00
52W Low
₹628.25
Operating Margin
40.00%
Profit Margin
28.93%
Revenue (TTM)
₹598.00
EBITDA
₹266.00
Net Income
₹173.00
Total Assets
₹2,808.00
Total Equity
₹2,410.00
Anthem Biosciences Share Price History - Stock Screener Chart
Screen ANTHEM historical share price movements with interactive charts. Analyze price trends and patterns.
Anthem Biosciences Company Profile - Fundamental Screener
Screen Anthem Biosciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ANTHEM shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE0CZ201020
Anthem Biosciences Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ANTHEM balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 2,808 | 2,398 | 2,015 | 1,619 | 1,034 | 787 |
| Current Assets | 1,737 | 1,482 | 1,323 | 1,098 | 616 | 403 |
| Fixed Assets | 705 | 483 | 449 | 329 | 361 | 306 |
| Liabilities | ||||||
| Total Liabilities | 2,808 | 2,398 | 2,015 | 1,619 | 1,034 | 787 |
| Current Liabilities | 72 | 135 | 110 | 41 | 47 | 118 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||
| Total Equity | 2,410 | 1,925 | 1,741 | 1,355 | 702 | 422 |
| Share Capital | 112 | 112 | 114 | 9 | 9 | 8 |
| Reserves & Surplus | 2,298 | 1,813 | 1,627 | 1,346 | 693 | 414 |
Screen ANTHEM income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun |
|---|---|---|---|---|---|---|
| Revenue | 598 | 563 | 497 | 522 | 553 | 358 |
| Expenses | 332 | 349 | 288 | 338 | 330 | 218 |
| EBITDA | 266 | 214 | 209 | 184 | 223 | 140 |
| Operating Profit % | 40.00% | 35.00% | 40.00% | 32.00% | 37.00% | 36.00% |
| Depreciation | 34 | 27 | 30 | 20 | 20 | 19 |
| Interest | 3 | 2 | 1 | 3 | 4 | 4 |
| Profit Before Tax | 230 | 186 | 178 | 161 | 200 | 118 |
| Tax | 56 | 51 | 96 | 37 | 38 | 36 |
| Net Profit | 173 | 136 | 83 | 124 | 162 | 82 |
| EPS | 3.09 | 2.43 | 1.48 | 2.22 | 2.90 | 1.47 |
Anthem Biosciences Cash Flow Screener - Liquidity Fundamentals
Screen ANTHEM cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March |
|---|---|---|---|---|---|---|
| Operating Activities | 418 | 140 | 306 | 333 | 278 | 166 |
| Investing Activities | -152 | -222 | -376 | -205 | -196 | -109 |
| Financing Activities | -134 | -77 | 64 | 181 | -63 | -48 |
| Net Cash Flow | 133 | -159 | -6 | 308 | 18 | 9 |
Screen ANTHEM shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jul | 2024-Dec |
|---|---|---|---|
| Promoter Holding | 74.69% | 76.88% | 77.23% |
| FII Holding | 1.67% | 0.00% | 0.00% |
| DII Holding | 7.22% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.61% | 0.00% | 0.00% |
| Other Holding | 6.81% | 23.12% | 22.77% |
| Shareholder Count | 217,681 | 761 | 16 |
Anthem Biosciences Dividend Screener - Share Yield Analysis
Screen ANTHEM dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Anthem Biosciences Index Membership - Market Screener Classification
Screen ANTHEM by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Anthem Biosciences Market Events Screener - Corporate Actions
Screen ANTHEM market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-08 | 2025-11-08 | Quarterly Result Announcement | NA | -6.08% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -0.83% |
Anthem Biosciences Competitors Screener - Peer Comparison
Screen ANTHEM competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 36,814 | 69.88 | 1,930 | 30.15% | 451 | 47.99 |
| Advanced Enzyme Tech | 3,499 | 22.84 | 670 | 1.44% | 134 | 55.82 |
| Genesis IBRC | 114 | -461.78 | 4 | % | 0 | 35.48 |
| Vivo Bio Tech | 70 | 17.05 | 52 | 13.19% | 7 | 52.63 |
| Shree Ganesh Bio-Tech | 28 | 24 | 14.55% | 0 | 64.94 | |
| Genomic Valley Biotech | 8 | 78.36 | 1 | 300.00% | 0 | 48.48 |
Anthem Biosciences Company Announcements - News Screener
Screen ANTHEM latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-08 | Compliance Certificate Under Regulation 74(5) Of SEBI (DP) Regulations 2018 | View |
| 2026-01-08 | Intimation Under Regulation 30 Of SEBI LODR Regulations With Reference To Issuance Of Corporate Guarantee | View |
| 2025-12-30 | Closure of Trading Window | View |
| 2025-12-15 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |
| 2025-11-11 | Intimation Of Violation Under CompanyS Code Of Conduct To Regulate Monitor And Report Trading By Designated Persons As Required Under SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations) | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-08 | Announcement under Regulation 30 (LODR)-Investor Presentation | View |
| 2025-11-08 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Saturday November 08 2025 | View |
| 2025-11-08 | Outcome Of The Board Meeting Held On Saturday November 08 2025 | View |
| 2025-10-28 | Intimation Of Violation Under CompanyS Code Of Conduct To Regulate Monitor And Report Trading By Designated Persons As Required Under SEBI (Prohibition Of Insider Trading) Regulations 2015 (SEBI PIT Regulations) | View |
| 2025-10-23 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-10-23 | Board Meeting Intimation for The Financial Results For Quarter And Half Year Ended September 30 2025 | View |
| 2025-10-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-29 | Closure of Trading Window | View |
| 2025-09-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | View |
| 2025-09-15 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-08-18 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | View |